ArticleP & T : a peer-reviewed journal for formulary management2013

Cardiometabolic consequences of therapy for chronic schizophrenia using second-generation antipsychotic agents in a medicaid population: clinical and economic evaluation.

Alex Ward et al.PubMed ↗Full text ↗

No numbers read from the abstract.